In colorectal cancer, ERCC2 overexpression failed to predict the survival time of patients receiving adjuvant chemotherapy [8], but the expression and prognosis ability of ERCC2 mRNA in GC are unreported. This evidence concerns the gene ERCC2 and colorectal cancer.